Major Shareholder Tenders All Shares into Servier Acquisition Offer

summarizeSummary

Access Industries, a significant shareholder, has tendered all of its 12.52% stake in Day One Biopharmaceuticals into Servier's $21.50 per share cash tender offer, confirming its support for the acquisition.

check_boxKey Events

• Major Shareholder Tenders Shares

  Access Industries, holding 12.52% of Day One Biopharmaceuticals, has tendered all 12,929,322 shares into Servier's tender offer.

• Confirms Acquisition Progress

  This action, valued at approximately $278 million, reinforces the progress of Servier's acquisition of Day One Biopharmaceuticals at $21.50 per share.

• Follows Regulatory Approval

  The tendering of shares occurs just days after the FTC granted early termination of the HSR waiting period, satisfying a major regulatory condition for the acquisition.

auto_awesomeAnalysis

This Schedule 13D/A filing confirms that Access Industries, a major investor holding 12.52% of Day One Biopharmaceuticals' common stock, has tendered all of its shares into the ongoing acquisition offer by Servier. This action, valued at approximately $278 million, signals strong shareholder support for the $21.50 per share cash tender offer. Coming shortly after the satisfaction of key regulatory conditions for the acquisition, this filing provides further assurance that the transaction is progressing towards completion. Investors should view this as a positive indicator for the deal's finalization.